Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Molecular Graphics & Modelling|February 24, 2009
A comparison of ligand based virtual screening methods and application to corticotropin releasing factor 1 receptorGary Tresadern, Daniele Bemporad, Trevor HoweBioorganic & Medicinal Chemistry|February 12, 2002
Application of non-parametric regression to quantitative structure-activity relationshipsJonathan D Hirst, T John McNeany, Trevor Howe, et al.Journal of Medicinal Chemistry|November 18, 2008
Assessment of additive/nonadditive effects in structure-activity relationships: implications for iterative drug designYogendra Patel, Valerie J Gillet, Trevor Howe, et al.Journal of Medicinal Chemistry|October 28, 2005
MetaSite: understanding metabolism in human cytochromes from the perspective of the chemistGabriele Cruciani, Emanuele Carosati, Benoit De Boeck, et al.British Journal of Pharmacology|February 3, 2005
CGH2466, a combined adenosine receptor antagonist, p38 mitogen-activated protein kinase and phosphodiesterase type 4 inhibitor with potent in vitro and in vivo anti-inflammatory activitiesAlexandre Trifilieff, Thomas H Keller, Neil J Press, et al.Journal of Medicinal Chemistry|March 18, 2009
Novel approach for chemotype hopping based on annotated databases of chemically feasible fragments and a prospective case study: new melanin concentrating hormone antagonistsJulen Oyarzabal, Trevor Howe, Jesús Alcazar, et al.Current Topics in Medicinal Chemistry|April 14, 2004
New highly potent and selective adenosine A(3) receptor antagonistsNeil J Press, Thomas H Keller, Pamela Tranter, et al.Bioorganic & Medicinal Chemistry Letters|September 24, 2011
Design and synthesis of a library of chemokine antagonistsGurdip Bhalay, Birgit Albrecht, Mohammed Akhlaq, et al.Bioorganic & Medicinal Chemistry Letters|August 17, 2002
8-Aryl xanthines potent inhibitors of phosphodiesterase 5Ruth Arnold, David Beer, Gurdip Bhalay, et al.Cell Genomics|June 30, 2023
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitisAndrew C Brown, Carla J Cohen, Olga Mielczarek, et al.Pageof 2